Other
Polypeptide hormones and structural analogues, other than insulin
HSN 2937 19 00 (Other polypeptide hormones and analogues) is subject to Narcotic Drugs and Psychotropic Substances (NDPS) import controls under Chapter VII-A of the NDPS Rules, 1985, with import of any scheduled substance requiring an import certificate under Rule 53 of those Rules. The Directorate General of Foreign Trade (DGFT) ITC (HS) Restricted-import policy condition No. 2 to Chapter 29 governs imports outside the medical and scientific-purpose special provision, and Central Board of Indirect Taxes and Customs (CBIC) Circular 23/2023-Cus mandates mandatory additional qualifiers in the import declaration for all Chapter 29 commodities.
- Import certificate from NDPS
- Import licence for drugs from CDSCO
- Registration certificate from CDSCO
Procedural directions for customs clearance are issued by: Directorate General of Foreign Trade, Central Board of Indirect Taxes and Customs.
- 1Obtain an import certificate under Rule 53 of the NDPS Rules, 1985 from the Central Bureau of Narcotics (cbn.nic.in) for any scheduled NDPS substance within this tariff line. Imports for medical and scientific purposes are permitted under the special provision of Chapter VII-A of the NDPS Rules, 1985; all other imports are governed by Appendix-I to the ITC (HS) Schedule per policy condition No. 2 to Chapter 29.Rule 53, Chapter VII-A of the NDPS Rules, 1985 · ITC (HS) policy condition No. 2 to Chapter 29
- 2Before the bill of entry is filed, upload all mandatory documents in e-Sanchit: Certificate of Analysis — Drug (document code 0010dc), Batch Release Certificate (0030dc), Label of Consignment (0110dc), Registration Certificate — Drugs (101dc1), and Import Licence for Drugs (9111dc). The proper officer will verify these uploads before granting out-of-charge where the bill has not been routed through the PGA for NOC.CBIC e-Sanchit document codes 0010dc, 0030dc, 0110dc, 101dc1, 9111dc
- 3Ensure the import declaration includes the mandatory additional qualifiers for Chapter 29 commodities as stipulated in Paragraphs 4.1 and 4.2 of CBIC Circular 23/2023-Cus, operative from 15 October 2023. Note that import of oxytocin is prohibited; import of oxytocin reference standards is allowed exclusively for test and analysis, subject to a test licence issued by DGCI/CDSCO, per S.O. 2357(E) and DGFT Notification 09/2015-2020 dated 23-05-2022.CBIC Circular 23/2023-Cus dated 30-09-2023 · S.O. 2357(E) dated 23-05-2022 · DGFT Notification 09/2015-2020 dated 23-05-2022
The critical error on this tariff line is conflating the NDPS import certificate with the CDSCO drug import licence: they are independent instruments issued by separate authorities, and customs out-of-charge requires both to be present in e-Sanchit. A second common trap is the oxytocin prohibition — the absolute bar on import applies to the commercial substance; only oxytocin reference standards for test and analysis, backed by a DGCI/CDSCO test licence, are permitted, and any consignment without that test licence is liable to outright confiscation.